L860-0379 Screening compound: methyl 4-(2-{[6-(benzylcarbamoyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl}acetamido)benzoate

L860-0379 Screening compound: methyl 4-(2-{[6-(benzylcarbamoyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl}acetamido)benzoate
L860-0379 Screening compound: methyl 4-(2-{[6-(benzylcarbamoyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl}acetamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L860-0379
methyl 4-(2-{[6-(benzylcarbamoyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl}acetamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L860-0379

Molecular Formula

C24H21N5O4S (C24 H21 N5 O4 S)

Compound Name

methyl 4-(2-{[6-(benzylcarbamoyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl}acetamido)benzoate

IUPAC name

methyl 4-(2-{[6-(benzylcarbamoyl)-[124]triazolo[43-a]pyridin-3-yl]sulfanyl}acetamido)benzoate

SMILES

COC(c(cc1)ccc1NC(CSc1nnc(cc2)n1cc2C(NCc1ccccc1)=O)=O)=O

InChI

InChI=1S/C24H21N5O4S/c1-33-23(32)17-7-10-19(11-8-17)26-21(30)15-34-24-28-27-20-12-9-18(14-29(20)24)22(31)25-13-16-5-3-2-4-6-16/h2-12,14H,13,15H2,1H3,(H,25,31)(H,26,30)

InChI Key

LIDYWDHRXQTLKN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27481510

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.53

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.117

Distribution Coefficient, logD

3.116

Water Solubility, LogSw

-3.47

Polar Surface Area

90.789

Acid Dissociation Constant (pKa)

11.14

Base Dissociation Constant (pKb)

-0.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

L860-0379 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L860-0379 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L860-0379?
Check Price and Availability of L860-0379, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L860-0379 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L860-0379
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L860-0379
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L860-0379 available by request